Studies have found that endometriosis affects 10 to 15 percent of women of child-bearing age. And yet, despite how common this disease is - and how utterly debilitating its symptoms can be - we still ...
USPTO grants patent to AIM ImmunoTech’s Ampligen for endometriosis treatment: Ocala, Florida Monday, October 7, 2024, 15:00 Hrs [IST] AIM ImmunoTech Inc. announced that the Unit ...